Takeda outlines strategies to expand into India
Takeda’s basic plan consists of the strategies for expanding the Takeda group’s presence in India and at the same time, to pursue productivity and cost-effectiveness as a whole
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Results from the Phase III study showed that Lixisenatide once-daily in combination with basal insulin (with or without sulfonylurea) significantly improved glycemic control. Sanofi-aventis R&D executive vice president